Letters
Streptokinase is more economical than alteplase
BMJ 1995; 311 doi: https://doi.org/10.1136/bmj.311.7018.1506 (Published 02 December 1995) Cite this as: BMJ 1995;311:1506
- J C Mucklow, Senior lecturer (clinical pharmacology)
- Department of Pharmacy Policy and Practice, Keele University, Keele ST5 5BG
EDITOR,--Marc Verstraete cites streptokinase and alteplase as alternative thrombolytic drugs for the management of myocardial infarction.1 His guidance on choice is confined to the statement that …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.